Better Health, Brighter Future
Corporate Governance
The Company’s purpose is to provide “Better Health for People, Brighter Future for the World.” In line with this purpose, the Company is pursuing a management framework appropriate for a values-based R&D-driven biopharmaceutical company that operates on a global scale. We are strengthening internal controls, thorough compliance and risk management, and establishing a structure that will allow agile decision-making that is also sound and transparent. Through these efforts, we will further improve our corporate governance, thereby maximizing corporate value.
JULY 11, 2022 Takeda Announces the Submission of its Corporate Governance Report to the Tokyo Stock Exchange |
JUNE 29, 2022 Takeda Announces New Assignments of Directors |
JUNE 29, 2022 Takeda updates Skill Matrix |
NOVEMBER 1, 2021 Takeda published Corporate Governance related Documents on its website |